Timepolio Asset Management
VC Fund
Seoul, South Korea
Timepolio Asset Management is an asset management firm.
- Total investments:
- 87
- Last investment:
- Lead investor:
- 10%
Last updated:
For AI agents: llms.txt
Industries Timepolio Asset Management invests in
Stages Timepolio Asset Management invests in
Countries Timepolio Asset Management invests in
Round sizes
Round size
- Series A
- $3.4M–$17M
- Series B
- $5.2M–$24M
- Series C
- $10M–$80M
Investment Focus
Industry
- Biotechnology 26 (30%)
- Health Care 15 (17%)
- Manufacturing 13 (15%)
- Pharmaceutical 11 (13%)
- Software 9 (10%)
Stage
- Series B 24 (28%)
- Series A 21 (24%)
- Series C 15 (17%)
- Seed 11 (13%)
- Venture - Series Unknown 6 (7%)
Country
- South Korea 63 (72%)
- United States 5 (6%)
- Russian Federation 1 (1%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Viralpick provides IT services for organizations including data analysis, automation, acquisition, and advertising services. | $37.1M / Series C / Sep 17, 2026 | ||
| HEM Pharma is a biotechnology firm that focuses on personalized microbiome healthcare, live biotherapeutic drug (LBP) development, microbiome analysis, and health-functional food manufacturing. The company leverages proprietary microbiome technologies to develop individualized health solutions and next-generation microbiome-based therapeutics. andsupporting personalized microbiome solutions and functional nutrition products. HEM Pharma has expanded internationally through its Japanese subsidiary and global research partnerships. | $38.3M / Post-IPO Debt / Aug 18, 2026 | ||
| Next Securities offers specialized trading services for professional investors and family offices. It provides securities brokerage, corporate finance advisory, project financing, derivatives trading, and digital account services. The firm delivers a comprehensive range of financial solutions to support investment activities and participation incapital markets. | $10.3M / Convertible Note / Jul 28, 2026 | ||
| The SMC Group is a social marketing company. | $13M / Jun 18, 2026 | ||
| Meissa is a drone-based construction tech startup that provides real-time 3D mapping and modeling. The company digitalizes sites with spatial data, such as design level comparison, and overlays floor plans collected by drone, as well as does three-dimensional modeling of projects, enabling companies to complete construction smartly. | Venture - Series Unknown / Apr 02, 2026 | ||
| Next Level Studio is a group of creative experts dedicated to generating new value for intellectual property. | $2.4M / Series A / Jan 27, 2026 | ||
| Bone is a defense tech company. It builds autonomous drones and mission-ready AI systems. It integrates advanced hardware, intelligent software, and end-to-end solutions to support complex operations across commercial, industrial, and defense applications. It develops autonomous robotics systems for national defense and disaster response. | $11.7M / Seed / Nov 18, 2025 | ||
| MediMabBio platform uses systems biology combined with sophisticated immunological solutions to identify significantly improving immuno-oncology drugs that can actively target a range of solid tumors. The antibody discovery I-O platform brings the advantages of rational drug design to large molecule therapeutic development. | $17.8M / Series B / Oct 24, 2025 | ||
| IMBiologics is a biotechnology company that develops antibody-based drug candidates for diseases such as cancer and immune-related conditions. It conducts research and development using its own platforms to discover new therapeutic molecules. | $29.5M / Series C / Oct 14, 2025 | ||
| Preneu is a manufacturer of unmanned aerial vehicles (UAVs) specializing in drone development across VTOL fixed-wing, helicopter, and multirotor configurations. The company also researches flight control systems, power management, and companion computing, enabling applications in defense, public safety, construction, and agriculture. | $10.9M / Series C / Jul 08, 2025 | ||
| See all 87 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Featured in Investor Lists
Recommended lists
FAQ
What does Timepolio Asset Management invest in?
Timepolio Asset Management invests primarily in Biotechnology, Health Care and Manufacturing startups, most often at Series B and Series A stage. Most of the 87 investments tracked by Shizune back companies in South Korea. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What round sizes does Timepolio Asset Management invest in?
Timepolio Asset Management typically joins rounds of $3.4M–$17M at Series A, $5.2M–$24M at Series B and $10M–$80M at Series C. These are whole funding-round sizes, not Timepolio Asset Management's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds Timepolio Asset Management took part in.
When did Timepolio Asset Management last invest?
The most recent investment recorded for Timepolio Asset Management closed in Sep 2026. Shizune tracks 87 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
